Patents

US 12721859 B1: Pharmaceutically acceptable ready-to-use ferric carboxymaltose compositions

Granted
2026-09-01
Filed
2025-03-19 application 19084135
Type
Utility · 8 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

A pharmaceutical product includes a sealed container and further includes a pharmaceutically suitable ready-to-use ferric carboxymaltose premix composition in the sealed container. The ferric carboxymaltose premix composition contains water, sodium chloride, and ferric carboxymaltose in an amount that includes about 2.0 mg to about 4.0 elemental iron/mL of the composition, preferably about 3.0 mg elemental iron/mL of the composition. The ferric carboxymaltose premix composition is stable in the sealed container at room-temperature (RT) for at least one month. A method of preparing the pharmaceutical product includes: (i) dissolving ferric carboxymaltose in water to form a concentrate; (ii) adjusting the pH of the concentrate to 5.0 to 7.0, preferably about 6.0; (iii) subjecting the pH-adjusted concentrate to addition of thermal energy; (iv) diluting the heat-treated concentrate in the presence of sodium chloride, and adjusting the pH to 5.0 to 7.0, preferably about 6.0, to form the ferric carboxymaltose premix composition; (v) aseptically filling the ferric carboxymaltose premix composition into the container; and (vi) sealing the container.

Source: PTBLXML, file of 2026-09-01 (ipgb20260901.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Baxter International Inc. 1,112 patentsUS company or organizationDeerfield, ILBAXTER INTERNATIONAL INC SEC filer EXACT medium confidence: identical full name, one of each nationallyPTBLXML, file of 2026-09-01
Baxter Healthcare SA 1,060 patentsForeign company or organizationGlattpark, CHPTBLXML, file of 2026-09-01

Inventors

InventorPlacePatentsPerson pageSource
Mahesh V ChaubalKildeer, IL4PTBLXML, file of 2026-09-01
Jason Robert ManteiVolo, ILPTBLXML, file of 2026-09-01
Kelly Ann ParkerBuffalo Grove, ILPTBLXML, file of 2026-09-01

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/7135PTBLXML, file of 2026-09-01
A61JContainers specially adapted for medical or pharmaceutical purposes; devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms; devices for administering food or medicines orally; baby comforters; devices for receiving spittleA61J1/10PTBLXML, file of 2026-09-01

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2026-02-20Assignment
Assignment of assignor's interest
CHAUBAL, MAHESH V signed 2025-03-19
MANTEI, JASON ROBERT signed 2025-03-19
BAXTER INTERNATIONAL INC. DEERFIELD, IL
BAXTER HEALTHCARE SA GLATTPWRK (OPFIKON)
73848/751PASDL, file of 2026-10-15
2025-05-13Assignment
Assignment of assignor's interest
CHAUBAL, MAHESH V signed 2025-03-19
PARKER, KELLY ANN signed 2025-03-19
MANTEI, JASON ROBERT signed 2025-03-19
BAXTER INTERNATIONAL INC. DEERFIELD, IL
BAXTER HEALTHCARE SA GLATTPWRK (OPFIKON)
71098/430PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.